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Experimental Studies with Methylhydrazine Derivatives 
W. Bollag 
Methylhydrazine compounds constitute a new class of antitumour substances 
whose mechanism of action appears to be different from that of other cytotoxic agents. 
Among a large series of hydrazines and hydrazides which have been synthesized 
in search of monoamine oxidase inhibitors, the first derivative found to possess a cer-
tain antitumour activity was i-methyl-2-benzyl-hydrazine (Bollag and Grunberg, 
1963): 
- C H 2 N H N H C H 3 
This compound which showed pronounced inhibition of several transplantable 
tumours in mice and rats had, however, a low therapeutic index and, furthermore, 
caused liver damage. 
Zeller et al. (1963), therefore, synthesized a large series of hydrazines in order 
to obtain a compound with better chemotherapeutic activity and lower toxicity. 
The systematic variation of the molecule revealed that active representatives of this 
chemical group were only found among compounds of the general formula: 
R - C H 2 N H N H C H 3 
The biological properties within this group showed a marked variation depending 
on the chemical structure of the radical R. 
Effect on transplantable t u m o u r s 
The methylhydrazine compounds were systematically tested on the following 
transplantable tumours: Ehrlich carcinoma, solid form, Ehrlich carcinoma, ascitic 
form and Crocker sarcoma S 180 in mice; Walker carcinosarcoma 256 and uterus 
epithelioma (Guerin) T8 in rats. The growth of these tumours is markedly influenc-
ed by many methylhydrazine derivatives. Among these, Ro 4-6467/1 = p-(N1-
methylhydrazinomethyl)-N-isopropyl benzamide hydrochloride or Natulan (Bollag, 
J963, 1964) exhibited a particularly favourable therapeutic index. 
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Natulan (Ro 4-6467/1): 
C H , 
C H , 
)CH N H CO r\ CH, NH NH CH,- HC1 
Tables 1-4 show the inhibitory activity of Natulan on Ehrlich carcinoma, solid 
form, Ehrlich carcinoma, ascitic form, Walker carcinosarcoma 256, and uterus 
epithelioma (Guerin) T8 . 
Tab. 1. Ehrlich carcinoma, solid form 
Natulan i.p., 5 times within seven days 
Natulan 
daily dose 
(mg/kg) 
Controls 
1 0 0 
2 0 0 
300 
400 
Tumour 
weight 
(mg) 
529 
158 
5° 
40 
37 
Weight 
change 
of mice (g) 
+ 1.2 
+0.2 
—2.2 
—2.8 
—4-3 
Tumour 
inhibition 
(%) 
0 
70.2 
90.6 
92-5 
93-o 
Tab. 2. Ehrlich ascites carcinoma 
Natulan i.p., 7 times within 9 days 
Natulan 
daily dose 
(mg/kg) 
Controls 
1 0 0 
2 0 0 
300 
400 
Survival 
time 
(days) 
10.2 
18.6 
23-4 
42.2 
40.8 
Prolongation 
of life 
(%) 
0 
80 
130 
310 
300 
Tab. 3. Walker carcinosarcoma 256 
Natulan i.p., 6 times within 8 days 
Natulan 
daily dose 
(mg/kg) 
Controls 
0 
10 
2 0 
3° 
Tumour 
weight 
(mg) 
4905 
954 
0 
0 
0 
Weight 
change 
of rats (g) 
4-22.6 
+ 23.0 
+ 20.7 
+ 12.8 
+ 7-8 
Tumour 
inhibition 
(%) 
0 
80.6 
1 0 0 
1 0 0 
1 0 0 
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Tab. 4. Uterus epithelioma (Guerin) T8 
Natulan i.p., 6 times within 8 days 
Natulan 
daily dose 
(mg/kg) 
Controls 
2-5 
5 
IO 
Tumour 
weight 
(mg) 
22496 
6908 
4261 
0 
Weight 
change 
of rats (g) 
+ 10.6 
+ 31.0 
+ 22.4 
+ 6.2 
Tumour 
inhibition 
(%) 
0 
69-3 
81.1 
1 0 0 
Natulan exerts a particularly marked inhibition on transplantable tumours in 
rats. In experiments with treatment beginning on the day after implantation, the 
growth of the Walker carcinosarcoma and of the uterus epithelioma T8 was com-
pletely suppressed by non-toxic doses. Natulan is not only effective when treatment 
has begun before the take of the tumour, it also exerts a therapeutic effect on well 
established tumours. If treatment of Walker tumours has begun as late as 5 days after 
implantation, i.e. when the tumour has already reached the size of an almond, a 
regression can be obtained. The regression of such tumours can be followed by his-
tological examination. 
Figs. 1 and 2 show that after treatment with Natulan the number of tumour 
cells already decreases markedly during the first 3 days. The tumour tissue is replaced 
by inflammatory tissue and finally by fibrous tissue. 
In some of the animals this regression is complete and no recurrence is observed 
within a period of 100 days. However, in other animals, although regression to al-
most non palpable nodules is obtained, this is only temporary, as tumour growth 
reappears in spite of continued treatment. 
With the Walker carcinosarcoma, drug resistance can develop within the same 
generation, whereas with Ehrlich carcinoma drug resistance could be observed only 
after continued treatment of 7 to 9 generations of inoculated mice. 
Effect of Natulan on other rapidly proliferating t i s s u e s 
Like all other antitumour agents, Natulan does not act selectively on tumour 
tissue. Other rapidly proliferating tissues such as the haemopoietic tissues, the ger-
minal epithelium and the hair follicles are also affected (Bollag and Theiss, 1964). 
Natulan exerts a considerable effect on haemopoiesis. All blood-forming systems are 
affected. Leukopoiesis and thrombopoiesis are markedly damaged while the erythro-
poiesis is influenced much less. Both lines of white blood cells, the myeloid and the 
lymphoid series, are depressed by Natulan. Depending on the species used, the in-
fluence on leukopoiesis varies considerably. Thus Natulan predominantly depresses 
the granulopoiesis in dogs, while in rats it mainly affects the lymphopoiesis. 
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Fig. i. Histological section of the peripheral zone of a Walker tumour, 8 days after implantation. The tumour 
tissue is in full proliferation. Many cells in mitosis. (Hematoxylin-eosin, magnification X 400) 
Walker tumour 
after 3 days' treatment with Natulan 
Fig. 2. Histological section of the peripheral zone of a Walker tumour, 8 days after implantation. Due to treat-
ment, the tumour cells have almost disappeared. Replacement of the tumour tissue by granulation tissue and 
fibrous tissue. (Hematoxylin-eosin, magnification x 400) 
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Tab . 5 shows the effect of Natulan on the leukopoiesis in rats. 
Tab. 5. Leukopoiesis in the rat 
Natulan 
Dose 
Initial 
values 
After 
2 weeks 
After 
4 weeks 
After 
6 weeks 
20 mg/kg 
per day 
leukocytes 
lymphocytes 
neutrophils 
10500 
7830 
2520 
8300 
6600 
1520 
4700 
3!9° 
1360 
2700 
1740 
8 6 0 
Initial 
values 
After 
2 weeks 
After 
4 weeks 
After 
G weeks 
70 mg/kg 
per day 
leukocytes 
lymphocytes 
neutrophils 
10500 
7830 
2520 
3100 
2030 
1020 
1800 
8 1 0 
9 4 0 
1400 
4 2 0 
940 
Initial 
values 
After 
2 days 
After 
4 days 
After 
6 days 
leukocytes 
lymphocytes 
neutrophils 
10500 
7830 
2520 
33°o 
2400 
8 8 0 
1800 
1050 
780 
7 0 0 
3 1 0 
3 8 0 
200 mg/kg 
per day 
Haemolysis is a manifestation of toxicity common to many hydrazine derivatives. 
I t is due to the formation of methaemoglobin and the appearance of Heinz-Ehrlich 
inclusion bodies in the erythrocytes. As a consequence of haemolysis, reticulocytosis 
and storage of haemosiderin in various organs are observed. 
M e c h a n i s m of act ion of methylhydraz ine derivat ives 
I. CYTOLOGIGAL STUDIES 
A. Ehrlich ascites carcinoma 
Cytological studies revealed that the substances belonging to the group of methyl-
hydrazine derivatives exert a marked influence on the mitotic cycle (Rutishauser 
and Bollag, 1963). The experiments were carried out on Ehrlich ascites carcinoma. 
The tumour used has a rather stable chromosomal variation pattern with a stemline 
chromosome number of 66. This hypertriploid tumour with 2 metacentric marker 
chromosomes showed no spontaneous chromosome or chromatid breaks. 
162 
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S1120962300026378
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 11 Jul 2017 at 15:52:36, subject to the Cambridge Core terms of use, available at
Proceedings of the First International Symposium on Antimitotics 
i. Mitotic index 
Under the influence of methylbenzylhydrazine (MBH) the mitotic index decreases 
very markedly. The mitotic index in the non-treated controls varies between 
5.3% and 9%. In the treated animals, depending on the dose of the cytotoxic agent 
and the lapse of time after its administration, the index falls to a minimum of 0.5 
to 0.6%, i.e. to about 1/10 of the control values (Tab. 6). 
Tab. 6. Mitotic index 
Dose Hrs after single 
injection 
Mitotic index 
in % 
Controls 8 9 
24 8.4 
48 5-3 
72 6.4 
200 mg/kg 8 0.6 
MBH i.p. 24 5.4 
48 3.4 
72 5-5 
300 mg/kg 24 0.8 
MBH i.p. 48 0.5 
2. Phase ratio 
The analysis of the different phases of the mitotic cycle shows a slight shift from 
prophase to metaphase. The percentage of ana- and telophases does not change 
significantly. 
3. Chromosome number 
The number of chromosomes in our hypertriploid ascites tumour with its stem-
line number (S) of 66 does not show any alteration in its chromosome variation pat-
tern under the influence of MBH. 
4. Chromosomal aberrations 
After the treatment with methylhydrazine derivatives a high number of chromo-
somal aberrations occurs. A few free chromatid breaks can be observed, however 
interchange and triradial recombinations prevail by far (Fig. 3). 
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S> 
V 
Fig. 3. Metaphase plate, 48 hrs after 400 mg/kg MBH. Chromosomal aberrations, in which some of the re-
combinations are pointed out as tr = translocation (interchange) 
The number of breaks depends on the dose of the drug and the lapse of time after 
the injection of methylhydrazine derivatives. In the next Tab. 7 the mean percentage 
of chromatid breaks is indicated. 1% breaks mean that in one of 100 investigated 
metaphase plates one chromatid break is found. In our calculation an interchange 
form is counted e.g. as 4, as this recombination is the consequence of 4 chromatid 
breaks. 
Tab. 7. Chromatid breaks 
Dose 
Hrs after single 
injection 
Mean percentage 
of breaks 
Controls 
200 mg/kg 
MBH i.p. 
400 mg/kg 
MBH i.p. 
8 
24 
48 
72 
48 
72 
168 
192 
0 
0 
3-3 
38.0 
29.0 
70.4 
280.0 
255-6 
39-6 
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From these results the following conclusions were drawn: 
The low mitotic index is interpreted as a suppression of mitosis brought about 
by a prolongation of the interphase. As the slight shift in distribution from prophase 
to metaphase is not followed by a decrease of ana- and telophase and is furthermore 
combined with a low mitotic index, a colchicine-like effect can be excluded. The 
chromosomal aberrations induced by the methylhydrazine derivatives show a spe-
cific pattern. Only chromatid breaks and chromatid reunions but no chromosome 
breakage could be observed. From this fact it may be inferred that the breaks are 
induced during or after deoxyribonucleic acid synthesis, i.e. either in the S or the 
G2 phase. Under the treatment with methylhydrazine derivatives there is no 
change in the chromosome number. This may imply that the cells presenting 
chromosomal aberrations are no more viable and do not survive the next cycle. 
B. Tissue culture 
The effect of methylhydrazine derivatives on tissue culture has been examined 
by several authors (Mosimann, Staiger, Rutishauser). In contrast to the definite 
effect of Natulan on mitosis and chromosomes in vivo, its influence on cells in tissue 
culture is very weak. A certain inhibitory effect on the growth of tissue cultures 
of Hela- and KB-cells has been seen, but only with the high doses of ioo to iooo y/ml 
medium. Primary rat kidney tissue cultures and tissue cultures of the human carci-
noma HEP 2 were hardly inhibited in their growth by Natulan. In primary rat kidney 
tissue culture 2000 y/ml did not induce any chromosomal aberrations. The enormous 
dose of 4000 y/ml did not interfere with the growth of HEP 2 cultures and induced 
only a very few chromosome breaks, however no chromatid breaks and no reunions. 
This discrepancy between the results in vitro and in vivo may be explained by the 
hypothesis that only a metabolite of Natulan exerts the cytotoxic effect. The azo-
derivative of Natulan, the only metabolite known to be effective in tumour inhibi-
tion experiments in vivo has been examined but has been found inactive in tissue 
culture. Thus we do not yet know the reason for the almost complete inactivity of 
Natulan in vitro. 
C. Autoradiographic studies 
The above-mentioned studies had revealed that the sensitive period of the cell 
is either the S or G2 period of the interphase. Further investigations were carried 
out on Ehrlich ascites carcinoma cells for obtaining information on the effect of Natulan 
on the DNA synthesis (Rutishauser and Bollag, 1967). We measured the incorpora-
tion of H3-thymidine in the DNA of the nucleus by autoradiography. H'-thymidine 
in a dose of 10 JJLC was administered to ascites tumour bearing mice. Ascites was 
taken 10 hrs after injection of H3-thymidine. Natulan was given at different intervals 
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before the administration of H3-thymidine. From Tab. 8 it can be seen that Natulan 
has a marked effect on the incorporation of H3-thymidine into DNA. 
Tab. 8. Effect of Natulan on thymidine incorporation 
(autoradiography of Ehrlich ascites carcinoma cells) 
H3-thymid 
200 mg/kg 
before H3-
200 mg/kg 
before H3-
Treatment 
ne 10 fie 
Natulan 8 hrs 
thymidine 10 JJLC 
Natulan 72 hrs 
thymidine 10 /uc 
Number of silver grains 
10 hrs after H3-thymidine injection 
Maximal value 
per nucleus 
92 
45 
46 
Mean value 
of all nuclei 
11.3 
4.8 
3-i 
Mean value 
of active nuclei 
17.2 
7-9 
6.7 
When Natulan was given 72 hrs before H3-thymidine the number of silver grains 
in the area of the nucleus decreased from 11.3 to 3.1 if we count all nuclei, or from 
17.2 to 6.7 if we count only the active nuclei. These latter nuclei undergoing the 
synthesizing period of the interphase constitute about 60% of all nuclei. Further-
more the highest number of silver grains in the controls amounts to 92 per nucleus, 
whereas the nuclei of Natulan treated animals reach only values of 46 per nucleus. 
From these results the conclusion can be drawn that the DNA synthesis is markedly 
inhibited, the percentage of inhibition ranging between 50 and 70%. 
These results are in good agreement with findings of other authors, who observed 
with other methods and on other tissues a marked inhibition of DNA synthesis by 
Natulan (Folsch et al., 1964; Weitzel; Trepel et al.). 
I I . BIOCHEMICAL AND PHYSIOCHEMICAL STUDIES 
We have just dealt with the inhibition of the synthesis of DNA by Natulan, which 
may be one of the possible mechanisms responsible for the cytotoxic activity. Many 
more factors may play a decisive role. Thus not only the deoxyribonucleic acid syn-
thesis but also the ribonucleic acid synthesis is inhibited (Weitzel; Trepel et al., 1966). 
Furthermore it has been established that Natulan interferes markedly with protein 
synthesis (Folsch et al., 1964; Koblet). 
Since the influence on the chromosomes is probably focussed on their main con-
stituent which is the deoxyribonucleic acid, in vitro studies have been performed with 
the latter (Berneis et al., 1963, 1964; Brookes, 1965). It is well known that the in-
fluence of radiation and alkylating agents cause the degradation of DNA whereby 
it is split into smaller fragments. The methylhydrazine derivatives likewise act by 
fragmentation of DNA but unlike nitrogen mustards only in the presence of oxygen. 
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Under Natulan treatment DNA remains intact in a nitrogen medium. These effects 
measured by the viscosity of aqueous DNA or by determining its molecular weight, 
are due to autoxidation of the methylhydrazine derivatives leading to the formation 
of hydrogen peroxide or O H radicals. The degradation of DNA in oxygen medium 
can be inhibited by addition of catalase (Fig. 4). 
0.8 
0.6 
0.4 
0.2 
0 40 80 120 160 180 hours 
Fig. 4. Changes in the specific viscosity of a 0.07% DNA solution containing 0.0005 rnol/1 Natulan 
O = in air # = in nitrogen 
• = in air with addition of catalase 
By other experiments it could be proven that the methylhydrazine derivatives 
promote reactions between peroxidic radicals and organic compounds such as for 
instance the deoxyribose (Berneis et al., 1964). 
The depolymerizing effect on DNA could not yet be confirmed in experiments 
in vivo (Koblet). However the methods available for such a proof may not be ade-
quate for discovering minor differences in weight and shape of DNA molecules. 
Natulan may also act by an alkylating mechanism. Brookes (1965) demonstrated, 
by using H "-labelled Natulan, that a methyl group of Natulan is transferred to 
the guanine part of DNA, thus methylating guanine to 7-methylguanine. This 
alkylation could be achieved only in vivo in the Ehrlich ascites carcinoma, but — unlike 
the nitrogen mustards — not in vitro, in the test tube or in tissue culture. Kreis et al. 
(1966) found in the urine of mice bearing Leukemia P 815 treated with C14-labelled 
Natulan not only large quantities of 7-methylguanine but in addition i-methylade-
nine and i-methylhypoxanthine. 
The methylation of the purine bases of DNA (guanine and adenine) may change 
the genetic code of the cells and disturb in this way the reduplication of DNA and 
the synthesis of RNA and proteins necessary for growth. Many more investigations 
point to the fact that the mechanism of action of methylhydrazine derivatives differs 
from that of other cytotoxic agents (Weitzel et al., 1964; Obrecht et al., 1964). 
In summarising it may be said that the methylhydrazine derivatives are known 
to possess a marked influence on preexisting DNA, as well as on the synthesis of DNA, 
^ a j . v \J \ ^ 
a 
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RNA and proteins, but that we ignore the exact mechanism responsible for the cy-
totoxic effect. Anyhow the mechanism of action must be different from that of other 
antitumour agents, as there does not exist a cross-resistance between Natulan and 
any compound of another class of cytotoxic agents. 
S u m m a r y 
Natulan (Procarbazine) is a methylhydrazine derivative which in animal exper-
iments inhibits a series of transplantable tumours. The Walker carcinoma is mark-
edly affected. Even well established Walker tumours disappear completely under 
Natulan treatment. Tumour tissue is replaced by fibrous tissue. Natulan does not 
act selectively on neoplastic tissue, it also depresses the growth of other rapidly 
proliferating tissues such as the bone marrow. 
As regards the mechanism of action the following data are known: Natulan 
lowers the mitotic index by prolonging the interphase and hindering the cell from 
entering into mitosis. In Ehrlich ascites tumour cells chromatid breaks were observed. 
Natulan depolymerizes deoxyribonucleic acid (DNA) in vitro. In vivo the synthesis 
of DNA is inhibited. Furthermore alkylation of purine bases has been demonstrat-
ed. All these mechanisms may be responsible for the cytotoxic effect of methyl-
hydrazine derivatives. Natulan does not possess cross-resistance towards other cy-
totoxic agents. This phenomenon is a further proof of its particular mechanism 
of action. 
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RIASSUNTO RESUME 
II Natulan (Procarbazina) e un derivato del-
la metilidrazina, che presenta una notevole azio-
ne inibitrice su di una serie di tumori trapian-
tabili neU'animale. Fortemente influenzato e in 
particolare il tumore di Walker nel ratto. Anche 
se ben radicati, i carcinomi di Walker possono 
scomparire completamente dopo trattamento 
con Natulan, in quanto il tessuto tumorale 
viene ad essere sostituito da tessuto connettivo. 
II Natulan non danneggia soltanto il tessuto 
neoplastico, ma anche altri tessuti a rapida pro-
liferazione, come ad esempio il midollo osseo. 
Per quanto riguarda il meccanismo d'azione e 
stato osservato quanto segue: il Natulan abbas-
sa l'indice mitotico, prolungando l'interfase ed 
impedendo in tal modo alia cellula di entrare 
in mitosi. Nel caso del carcinoma ascitico di 
Ehrlich sono state osservate rotture cromatidi-
che. In vitro il Natulan depolimerizza l'ADN. In 
vivo, la sintesi dell'ADN viene impedita ed e 
stata dimostrata la alchilazione delle basi purini-
che. Tutti questi meccanismi possono essere 
responsabili dell'effetto citostatico del Natulan. 
D'altra parte, non esiste resistenza crociata fra 
Natulan e altri agenti citostatici, il che dimostra 
che il Natulan possiede il suo proprio mecca-
nismo d'azione. 
Le Natulan (Procarbazine) est un derive de 
la methylhydrazine, qui montre une action in-
hibitrice marquee sur une serie de tumeurs 
transplantables chez l'animal. Particulierement 
la tumeur de Walker du rat est fortement in-
fluencee. Meme des carcinomes de Walker bien 
etablis peuvent disparaitre completement sous 
traitement au Natulan, le tissu tumoral etant 
remplace par du tissu conjonctif. Le Natulan 
n'endommage pas seulement le tissu neoplasi-
que mais aussi d'autres tissus a proliferation 
rapide comme par exemple la moelle osseuse. En 
ce qui concerne le mecanisme d'action, les faits 
suivants ont ete notes: le Natulan abaisse l'in-
dex mitotique, en prolongeant l'interphase, em-
pechant de ce fait la cellule d'entrer en mitose. 
Dans le cas du carcinome ascitique d'Ehrlich, 
des ruptures de chromatides ont ete observees. 
In vitro, le Natulan depolymerise l'acide de-
soxyribonucleique (ADN). In vivo, la synthese 
de l'ADN est inhibee et l'alchylation de bases 
puriniques a ete demontree. Tous ces mecanis-
mes peuvent etre responsables de l'effet cyto-
statique du Natulan. D'autre part, il n'existe 
pas de resistance croisee entre le Natulan et 
d'autres agents cytostatiques, ce qui demontre 
que le Natulan possede son propre mecanisme 
d'action. 
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ZUSAMMENFASSUNG 
Natulan (Procarbazin) ist eine Methylhydrazinverbindung, die im Tierversuch eine deutliche 
Hemmwirkung auf eine Reihe von transplantablen Geschwulsten zeigt. Der Walker-Tumor der 
Ratte wird besonders stark beeinflusst. Auch bereits etablierte Walker-Karzinome konnen noch 
vollstandig zur Riickbildung gebracht werden, wobei das Tumorgewebe durch Narbengewebe er-
setzt wird. Natulan schadigt nicht nur neoplastisches Gewebe, sondern auch andere rasch proli-
ferierende Gewebe wie z.B. das Knochenmark. Ober den Wirkungsmechanismus sind folgende Da-
ten bekannt: Natulan senkt den Mitoseindex, indem es die Interphase verlangert und dadurch die 
Zelle am Eintritt in die Mitose hindert. Chromatidbruche wurden an den Zellen des Ehrlich-
Aszites-Karzinoms beobachtet. Natulan depolymerisiert in vitro die Desoxyribonukleinsaure 
(DNS). In vivo wird die Synthese von DNS gehemmt. Es kommt ferner zu einer Alkylierung 
von Purinbasen. Alle diese Mechanismen konnen fur die cytostatische Wirkung von Natulan ver-
antwortlich sein. Natulan besitzt keine Kreuzresistenz gegeniiber anderen Cytostatica. Dieses 
Phanomen ist ein weiterer Hinweis dafur, dass Natulan einen besonderen Wirkungsmechanismus 
aufweist. 
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